1
Michael A Boss, John H Kenten, John S Emtage, Clive R Wood: Multichain polypeptides or proteins and processes for their production. Celltech, Cushman Darby & Cushman, March 28, 1989: US04816397 (816 worldwide citation)

Multichain polypeptides or proteins and processes for their production in cells of host organisms which have been transformed by recombinant DNA techniques. According to a first aspect of the present invention, there is provided a process for producing a heterologous multichain polypeptide or protei ...


2
Uma Ananth, Michael A Boss, William K Seltzer, Charleen M Sullivan: Mutations relating to X-linked charcot-marie-tooth disease. Athena Diagnostics, Hamilton Brook Smith & Reynolds P C, December 14, 1999: US06001576 (2 worldwide citation)

Specific mutations in the connexin-32 gene that are associated with X-linked Charcot-Marie-Tooth (CMT) disease are disclosed. Methods of diagnosing X-linked CMT disease are also disclosed. Methods include hybridization analysis, such as Southern or Northern analysis, which use hybridization of mutan ...


3
Michael A Boss: MRI phantom, method for making same and acquiring an MRI image. NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY, Office of Chief Counsel for National Institute of Standards and Technology, September 25, 2018: US10082553

A magnetic resonance imaging (MRI) phantom includes an outer container that includes a first portion comprising a first wall; a second portion opposingly disposed to the first portion and sealingly engaged to the first portion, the second portion including a second wall; and an internal volume bound ...


4
Alfred M Ajami, Michael A Boss, Jesse Paterson: Compounds for treating autoimmune and demyelinating diseases. Hamilton Brook Smith & Reynolds PC, August 24, 2006: US20060189546-A1

A method of treating a patient suffering from an inflammatory and/or demyelinating disorders, comprising administering to said patient a therapeutically effective amount of a compound of formula (A) or a pharmaceutically acceptable salt thereof. Definitions for the variables are provided therein.


5
Uma Anans, Michael A Boss, William K Seltser, Charleen M Sullivan: New transversion relevant to x-linked charcot-marie- tooth disease. Athena Diagnostics, January 11, 2000: JP2000-004888

PROBLEM TO BE SOLVED: To diagnose X-linked Charcot-Marie-Tooth disease by detecting the transversion of a codon in a specific region in an individual connexins-32 gene and using this transversion as a marker for X-linked Charcot-Marie-Tooth disease to discriminate from other neuropathy. SOLUTION: By ...